Key facts
- This page summarizes Chee Keong Yap's Form 3 filing for BioNexus Gene Lab Corp (BGLC).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 31 Jul 2026, 17:03.
Chee Keong Yap - 07 Mar 2022 Form 3 Insider Report for BioNexus Gene Lab Corp (BGLC)
- Reporting relationship
- Director
- Issuer ticker
- BGLC
- Reported as of
- 07 Mar 2022
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 31 Jul 2026, 17:03:34 UTC
- Next SEC filing
- 04 Oct 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Keong Yap Chee
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Chee Keong Yap filed Form 3 for BioNexus Gene Lab Corp (BGLC) on 31 Jul 2026.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0001994541
Primary reporting owner
Yap Chee Keong
- Relationship
- Director
- Address
- 10-2 TOWER B, VERTICAL BUSINESS SUITE, 8 JALAN KERINCHI, KUALA LUMPUR, MALAYSIA
- Signature
- /s/ Keong Yap Chee
- Signature date
- 31 Jul 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BGLC
holding
COMMON STOCK
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 0
- Date
- 07 Mar 2022
- Ownership
- Direct
* marks a reported price that did not pass the local price check.